Mass spectrometry measurement of plasma hepcidin for the prediction of iron overload.

Abstract

BACKGROUND:

Hepcidin has emerged as the primary regulator of iron homeostasis. Previous studies on assessing urinary hepcidin are limited. We developed a method for quantifying hepcidin-25 (Hep-25) in plasma using surface-enhanced laser-desorption-ionization time-of-flight mass spectrometry (SELDI-TOF/MS) and a 25-AA peptide as reference standard. The aims of the study were 1) to assess the performance of this method in different conditions of iron metabolism disorders; 2) to assess the diagnostic validity of non-invasive serum biomarkers in the identification of iron overload.

METHODS:

Validation of the method was performed in 10 patients with type I hemochromatosis (HE) and in 177 subjects previously enrolled in a general population epidemiological study. Among the latter group, 17 had non-alcoholic fatty liver disease, 10 had chronic hepatitis C, and 150 subjects had normal ultrasound, normal liver function tests (LFTs), an alcohol intake < 20 g ethanol/day and were negative for the C282Y mutation. The following biomarkers were assayed in each case: plasma Hep-25, C282Y and H63D mutations of the HFE gene; serum iron, ferritin (SF), transferrin saturation, transaminases, γ-glutamyltransferase (GGT), glucose, insulin, total cholesterol, high-density lipoprotein (HDL)-cholesterol, low-density lipoprotein (LDL)-cholesterol and triglycerides.

RESULTS:

Plasma Hep-25 concentrations were higher in HCV+ patients (26.3 ± 7.2 nmol/L) than in controls, and correlated positively with SF (p < 0.001). H63D heterozygous subjects revealed a pattern of iron overload that was significantly higher than H63D wild type subjects. Analyzing the data with the Biomarker Pattern 5.0.2. software to identify the most significant biomarkers for discriminating between HE cases and controls allowed us to produce an algorithm with four terminal nodes, which included glucose > 4.8 mmol/L and Hep-25/SF ratio ≤ 6.6 as the main splitters. These variables enabled the correct diagnosis of HE with 100% sensitivity, 93% specificity and an area under the receiver operating characteristic (ROC) curve of 0.993.

CONCLUSIONS:

Our plasma Hep-25 mass spectrometry method yields measurements that reflect pathological and genetic influences; simple non-invasive biomarkers (Hep-25/SF ratio and glucose) can predict the presence of HE.

• Authors: Annarosa Floreani, Filippo Navaglia, Erik Rosa Rizzotto, Daniela Basso, Maria Chiaramonte, Andrea Padoan, Ioannis Petridis, Nora Cazzagon, Roberto Testa, Maurizio Marra, Mario Plebani
• Journal: Clinical chemistry and laboratory medicine (Clin Chem Lab Med) Vol. 49 Issue 2 Pg. 197-206 (Feb 2011) ISSN: 1437-4331 [Electronic] Germany
• PMID: 21143008 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Antimicrobial Cationic Peptides
• Biomarkers
• HAMP protein, human
• Hepcidins

Topics

• Adolescent
• Adult
• Aged
• Aged, 80 and over
• Antimicrobial Cationic Peptides (blood)
• Biomarkers (blood)
• Blood Chemical Analysis (methods)
• Child
• Hepcidins
• Humans
• Iron Overload (blood, diagnosis)
• Male
• Mass Spectrometry (methods)
• Middle Aged
• Reproducibility of Results
• Young Adult